14 Oct A Cancer vaccine could be ready by 2030

Posted by - Rocío González

Cancer is one of the leading causes of death worldwide. For years, clinical trials have been underway in different parts of the world to find a cure for this global problem, but to no avail. However, that could be about to end. A German biotech company is conducting clinical trials for a cancer vaccine. We at our medical translation agency hope that such a vaccine will soon become a reality.

mRNA technology

Coronavirus vaccines rely mostly on a technology known as messenger RNA, mRNA, used by both Pfizer and BioNTech. Well, this same technology could serve as the basis for a technology company’s development of the first cancer vaccine, which would be available by 2030.

Thanks to this development, BioNTech, which was looking for cancer solutions before the outbreak of the pandemic, has managed to launch several clinical trials to use mRNA as a cancer vaccine. These experimental studies are focused on achieving novel treatments that can combat various pathologies, as well as tumours and melanomas.

The functioning of mRNA technology is focused on providing cells with genetic mechanisms so that they can naturally produce the necessary antigens.

Medical translation and cancer vaccines

Language can be a barrier to the dissemination of scientific knowledge. However, it is one of the easiest to remove: through the role of the translator. And not just any translator, but a medical translator, a professional with the specialised knowledge needed to break down this barrier and spread scientific knowledge to all audiences, from health professionals to the general public.

This is the key role played by medical translators when translating clinical trials, which can be of vital importance when it comes to finding the right solution to medical problems such as cancer. Medical translators will ensure that the original text, whether intended for the healthcare professional community or the general public, reaches its target audience just as it was prepared in its original language, with the same informative accuracy and nuances.